Tiedemann Advisors, LLC Eli Lilly & CO Transaction History

Tiedemann Advisors, LLC

$2.31 Billion
Q3 2023

A detailed history of Tiedemann Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Tiedemann Advisors, LLC holds 5,308 shares of LLY stock, worth $4.77 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

5,308

Previous 569 832.86%

Holding current value

$4.77 Million

Previous $266,000 971.8%

% of portfolio

0.12%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $2.06 Million - $2.84 Million	4,739 Added 832.86%	5,308 $2.85 Million
Q2 2023 Jul 20, 2023	BUY	$350.74 - $468.98 $199,571 - $266,849	569 New	569 $266,000
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $1.57 Million - $1.93 Million	-7,092 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$180.55 - $233.54 $98,219 - $127,045	-544 Reduced 7.12%	7,092 $1.63 Million
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $22,676 - $29,355	138 Added 1.84%	7,636 $1.43 Million

Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $10,697 - $14,155	82 Added 1.11%	7,498 $1.27 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $292 - $338	-2 Reduced 0.03%	7,416 $1.1 Million
Q2 2020 Nov 12, 2020	BUY	$136.42 - $164.18 $1.01 Million - $1.22 Million	7,418 New	7,418 $1.22 Million
Q2 2020 Aug 05, 2020	SELL	$136.42 - $164.18 $1.01 Million - $1.22 Million	-7,423 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$119.05 - $147.35 $84,763 - $104,913	712 Added 10.61%	7,423 $1.03 Million
Q4 2019 Feb 12, 2020	SELL	$106.92 - $132.43 $113,549 - $140,640	-1,062 Reduced 13.66%	6,711 $882,000
Q3 2019 Nov 06, 2019	SELL	$106.79 - $116.16 $6,941 - $7,550	-65 Reduced 0.83%	7,773 $871,000
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $299,133 - $349,164	-2,700 Reduced 25.62%	7,838 $867,000
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $18,588 - $21,880	167 Added 1.61%	10,538 $1.37 Million
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $826,867 - $926,341	7,808 Added 304.64%	10,371 $1.2 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $8,328 - $10,409	-97 Reduced 3.65%	2,563 $275,000
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $671,534 - $770,712	-8,871 Reduced 76.93%	2,660 $228,000
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $180,575 - $200,420	2,343 Added 25.5%	11,531 $451,000
Q2 2017 Aug 14, 2017	BUY	N/A	9,188	9,188 $756,000

Others Institutions Holding LLY

# of Institutions

3,722

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $853B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiedemann Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tiedemann Advisors, LLC with notifications on news.

Account

Tiedemann Advisors, LLC Eli Lilly & CO Transaction History